SeraCare Life Sciences (SRLS) agrees to be acquired for $80.8M by PE firm Linden Capital...

|By:, SA News Editor

SeraCare Life Sciences (SRLS) agrees to be acquired for $80.8M by PE firm Linden Capital Partners. The $4/share deal reflects a premium of 19% to Friday's closing price. SRLS, which supplies diagnostic control products for HIV, plasma-derived reagents and contract research services, had said last year it was exploring strategic alternatives.